|
Market Closed -
OTC Markets
15:50:47 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 14.56 USD | +2.39% |
|
-3.26% | +9.56% |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,318.66 | +18.19% | 29 | |||||||
| 277.91 | +4.64% | 22 | |||||||
| 277.31 | +7.85% | 29 | |||||||
| 373.71 | +8.57% | 19 | |||||||
| 153.34 | +11.65% | 22 | |||||||
| 212.3 | +34.09% | 23 | |||||||
| 388.03 | +2.83% | 29 | |||||||
| 310.17 | +12.2% | 23 | |||||||
| 158.15 | +10.04% | 27 | |||||||
| 28.88 | +4.17% | 26 | |||||||
| 569.19 | +10.43% | 27 | |||||||
| 66.42 | +4.36% | 24 | |||||||
| 94.06 | +28.39% | 24 | |||||||
| 21.61 | +22.08% | 21 | |||||||
| 9,323.33 | +45.18% | 15 | |||||||
| 6,603.31 | +16.54% | 16 | |||||||
| 58.22 | +20.87% | 18 | |||||||
| 41.91 | +12.99% | 11 | |||||||
| 71.35 | +67.22% | 17 | |||||||
| Average | 1,070.94 | +18.02% | 22 | ||||||
| Weighted average by Cap. | 714.81 | +13.63% | 25 |
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
- Sector Astellas Pharma Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















